Pfizer’s drug helps people with rare lung cancer live longer, data shows
Sixty percent of the patients treated with Pfizer’s Lorbrena drug, for a rare form of advanced lung cancer, were alive without disease progression.
Drugs
Health
Pharma
Drugs
Health
Pharma
Hunger, famine, stare at displaced Sudanese, WHO appeals for funds
Eighteen million people are “acutely” hungry in conflict-ridden Sudan as a famine is on the horizon and 800,000 civilians get ready for large-scale.
Health
Medical
Pharma
Medical education in the UK inflicting ‘pervasive harm’ on students: Expert
Technology-based medical training has led to junior doctors avoiding the ward to stick to the electronic tablet — a healthcare crisis that will.
Drugs
Health
Pharma
Biogen’s ALS drug gets European Commission’s marketing nod
The European Commission has granted marketing approval for Biogen Inc.’s therapy for the treatment of a form of amyotrophic lateral sclerosis.
Drugs
Health
Pharma
US reports a third human case of highly pathogenic avian influenza
A dairy farm worker in Michigan, US, has been infected with highly pathogenic avian influenza from sick cows —the third such case in America.
Drugs
Health
Pharma
J & J to buy rights for experimental skin disorder drug for $1.25 billion
Johnson & Johnson has agreed to buy the rights for an investigational skin disorder treatment from Numab Therapeutics for $1.25 billion.
Drugs
Health
Pharma
US drug regulator clears Amgen’s biosimilar to treat rare blood disorder
The US drug regulator has approved Amen’s biosimilar, Bkemv, to treat rare blood disorders, according to a statement from the Food and Drug.
Drugs
Health
Pharma
Air pollution triggering heart diseases across the globe: WHF report
About 70% of the 4.2 million deaths in 2019 attributed to air pollution were caused by cardiovascular conditions — ischaemic heart disease and.
Drugs
Health
Pharma
FDA panel rejects Novo Nordisk’s weekly jab to treat type 1 diabetes
The Endocrinologic and Metabolic Drugs Advisory Committee of the FDA refused approval for a once-weekly jab to control blood sugar levels in people.
Drugs
Health
Pharma
Pfizer Inc. unveils a new $1.5 billion plan to cut costs as vaccine sales fall
Pfizer Inc., announced a $1.5 billion “multi-year” savings plan to cut costs of goods sold, on top of a similar $4 billion initiative.